Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| PHARMACOLOGY II | PHA3114141 | Fall Semester | 2+0 | 2 | 4 |
| Course Program | Çarşamba 09:00-09:45 Çarşamba 10:00-10:45 |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | English |
| Course Level | First Cycle (Bachelor's Degree) |
| Course Type | Required |
| Course Coordinator | Assist.Prof. Çağlar MACİT |
| Name of Lecturer(s) | Assist.Prof. Çağlar MACİT |
| Assistant(s) | none |
| Aim | To teach the student about autocoids and their importance, Autonomic Nervous System and its drugs, Cardiovascular System diseases and the drugs used in their treatment, and Respiratory system diseases and the drugs used in their treatment. |
| Course Content | This course contains; Introduction to autacoids, histamine and antihistaminics,Endotheline and NO/Arahidonic acid metabolites,Serotonin and Renin-Angiotensin-Kinin,Introduction to autonomic nervous system and parasympathomimetic drugs,Parasympatholytic drugs,Sympathomimetic drugs and ganglion blockers,Antihypertensive drugs and diuretics I,Antihypertensive drugs and diuretics II,Congestive heart failure and antianginal drugs,Hypolipidemic agents,Anticoagulants and arrhythmics,Antitussives, mucolytics and expectorants,Bronchodilators,Drugs used in electrolite and acid-base imbalance disorders. |
| Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
| 1. Know the term of autacoid. | 16, 9 | C |
| 1.1. Define histamine and antihistaminics. | 16, 9 | C |
| 1.2. Know the endothelin, nitric oxide, Arachidonic acid metabolites | 16, 9 | C |
| 1.3. Know the serotonin, renin angiotensin, kinins. | 16, 9 | C |
| 2. Know the autonomic nervous system. | 16, 9 | C |
| 2.1. Summarize the pharmacokinetics, pharmacodynamics, side effects, contraindications and drug interactions of the autonomic nervous system drugs. | 16, 9 | C |
| 2.2. Interpret the mechanisms of autonomic nervous system drugs. | 16, 9 | C |
| 3. Discuss the pharmacokinetics, pharmacodynamics, side effect profiles and drug interactions of cardiovascular system drugs. | 16, 9 | C |
| 3.1. Interpret the mechanism of cardiovascular system drugs. | 16, 9 | C |
| 3.2. Give examples to drugs used in cardiovascular system diseases. | 16, 9 | C |
| 4. Discuss the pharmacokinetics, pharmacodynamics, side effect profiles and drug interactions of respiratory system drugs. | 16, 9 | C |
| 4.1. Interpret the mechanism of respiratory system drugs. | 16, 9 | C |
| 4.2. Give examples to drugs used in cardiovascular system diseases. | 16, 9 | C |
| Teaching Methods: | 16: Question - Answer Technique, 9: Lecture Method |
| Assessment Methods: | C: Multiple-Choice Exam |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Introduction to autacoids, histamine and antihistaminics | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 2 | Endotheline and NO/Arahidonic acid metabolites | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 3 | Serotonin and Renin-Angiotensin-Kinin | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 4 | Introduction to autonomic nervous system and parasympathomimetic drugs | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 5 | Parasympatholytic drugs | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 6 | Sympathomimetic drugs and ganglion blockers | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 7 | Antihypertensive drugs and diuretics I | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 8 | Antihypertensive drugs and diuretics II | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 9 | Congestive heart failure and antianginal drugs | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 10 | Hypolipidemic agents | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 11 | Anticoagulants and arrhythmics | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 12 | Antitussives, mucolytics and expectorants | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 13 | Bronchodilators | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 14 | Drugs used in electrolite and acid-base imbalance disorders | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| Resources |
| 1.Kayaalp, SO: Rasyonel Tedavi Yönünden Tıbbi Farmakoloji, Ankara. 2.Hardman JG, Limbird LE, Eds.: Goodman and Gilman’s The Pharmacological Basis of Therapeutics, New York. 3.Katzung & Trevor: Farmakoloji, Ankara. |
| 1, 2, 3, Lecturer notes |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | PQ-1. Skilfully use information technology to access, follow, evaluate and apply current knowledge in the field of Pharmaceutical Sciences. | X | |||||
| 2 | PQ-2. Have advanced knowledge in APIs and DPs. | X | |||||
| 3 | PQ-3. Collaborate with the experts for collection, interpretation, application and declaration of data in Pharmaceutical Sciences field. | X | |||||
| 4 | PQ-4. Provide best patient counseling services and medication therapy management using his/her knowledge and pharmaceutical information systems to improve the quality of life and safety of patient. | X | |||||
| 5 | PQ-5. Capable of organizing and administering a drugstore as per responsibilities prescribed under the Pharmacy Law, using skills, knowledge and advanced technology systems. | X | |||||
| 6 | PQ-6. Skilfully use computer programs and advanced technology related to the Pharmaceutical Sciences. | X | |||||
| 7 | PQ-7. Provide solutions to the professional issues using scientific knowledge and data. | X | |||||
| 8 | PQ-8. Perform identification, quality control and standardization of the drug products. | X | |||||
| 9 | PQ-9. Prepare and implement developmental plans for his/her subordinates, frequently evaluate their progress and make necessary adjustments. | X | |||||
| 10 | PQ-10. Capable of conducting independent studies with his/her advanced knowledge in pharmaceutical sciences, takes responsibilities in professional organizations and efficiently collaborates with the members of his/her own organization as well as other organizations. | X | |||||
| 11 | PQ-11. Clearly show signs of adoption of life-long learning and openness to further development. | X | |||||
| 12 | PQ-12. Critically evaluate their knowledge in pharmaceutical sciences. | X | |||||
| 13 | PQ-13. Closely follow and evaluate the national and international professional developments. | X | |||||
| 14 | PQ-14. Record and document all professional activities and applications. | X | |||||
| 15 | PQ-15. Communicate all necessary information about medicines to patient, medical personnel and public. | X | |||||
| 16 | PQ-16. Proficient in English to communicate and follow current knowledge in pharmaceutical sciences. | X | |||||
| 17 | PQ-17. Inform officials and organizations about the issues with the quality assurance of pharmaceutical products. | X | |||||
| 18 | PQ-18. Actively involve in the preparation of APIs, every stage of the formulation and production of DPs. | X | |||||
| 19 | PQ-19. Knowledgable in the regulatory rules of new drug application, data protection and patent issues and understand their interrelationship. | X | |||||
| 20 | PQ-20. Have awareness of his/her duties, rights and responsibilities and act based on Pharmacy Law and high professional ethical standards. | X | |||||
| 21 | PQ-21. Familiar with and actively pursue the personal and public health, environmental, and work safety issues. | X | |||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 40 | |
| Rate of Final Exam to Success | 60 | |
| Total | 100 | |
| ECTS / Workload Table | ||||||
| Activities | Number of | Duration(Hour) | Total Workload(Hour) | |||
| Course Hours | 14 | 2 | 28 | |||
| Guided Problem Solving | 14 | 1 | 14 | |||
| Resolution of Homework Problems and Submission as a Report | 0 | 0 | 0 | |||
| Term Project | 0 | 0 | 0 | |||
| Presentation of Project / Seminar | 0 | 0 | 0 | |||
| Quiz | 0 | 0 | 0 | |||
| Midterm Exam | 1 | 31 | 31 | |||
| General Exam | 1 | 36 | 36 | |||
| Performance Task, Maintenance Plan | 0 | 0 | 0 | |||
| Total Workload(Hour) | 109 | |||||
| Dersin AKTS Kredisi = Toplam İş Yükü (Saat)/30*=(109/30) | 4 | |||||
| ECTS of the course: 30 hours of work is counted as 1 ECTS credit. | ||||||
Detail Informations of the Course
Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| PHARMACOLOGY II | PHA3114141 | Fall Semester | 2+0 | 2 | 4 |
| Course Program | Çarşamba 09:00-09:45 Çarşamba 10:00-10:45 |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | English |
| Course Level | First Cycle (Bachelor's Degree) |
| Course Type | Required |
| Course Coordinator | Assist.Prof. Çağlar MACİT |
| Name of Lecturer(s) | Assist.Prof. Çağlar MACİT |
| Assistant(s) | none |
| Aim | To teach the student about autocoids and their importance, Autonomic Nervous System and its drugs, Cardiovascular System diseases and the drugs used in their treatment, and Respiratory system diseases and the drugs used in their treatment. |
| Course Content | This course contains; Introduction to autacoids, histamine and antihistaminics,Endotheline and NO/Arahidonic acid metabolites,Serotonin and Renin-Angiotensin-Kinin,Introduction to autonomic nervous system and parasympathomimetic drugs,Parasympatholytic drugs,Sympathomimetic drugs and ganglion blockers,Antihypertensive drugs and diuretics I,Antihypertensive drugs and diuretics II,Congestive heart failure and antianginal drugs,Hypolipidemic agents,Anticoagulants and arrhythmics,Antitussives, mucolytics and expectorants,Bronchodilators,Drugs used in electrolite and acid-base imbalance disorders. |
| Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
| 1. Know the term of autacoid. | 16, 9 | C |
| 1.1. Define histamine and antihistaminics. | 16, 9 | C |
| 1.2. Know the endothelin, nitric oxide, Arachidonic acid metabolites | 16, 9 | C |
| 1.3. Know the serotonin, renin angiotensin, kinins. | 16, 9 | C |
| 2. Know the autonomic nervous system. | 16, 9 | C |
| 2.1. Summarize the pharmacokinetics, pharmacodynamics, side effects, contraindications and drug interactions of the autonomic nervous system drugs. | 16, 9 | C |
| 2.2. Interpret the mechanisms of autonomic nervous system drugs. | 16, 9 | C |
| 3. Discuss the pharmacokinetics, pharmacodynamics, side effect profiles and drug interactions of cardiovascular system drugs. | 16, 9 | C |
| 3.1. Interpret the mechanism of cardiovascular system drugs. | 16, 9 | C |
| 3.2. Give examples to drugs used in cardiovascular system diseases. | 16, 9 | C |
| 4. Discuss the pharmacokinetics, pharmacodynamics, side effect profiles and drug interactions of respiratory system drugs. | 16, 9 | C |
| 4.1. Interpret the mechanism of respiratory system drugs. | 16, 9 | C |
| 4.2. Give examples to drugs used in cardiovascular system diseases. | 16, 9 | C |
| Teaching Methods: | 16: Question - Answer Technique, 9: Lecture Method |
| Assessment Methods: | C: Multiple-Choice Exam |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Introduction to autacoids, histamine and antihistaminics | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 2 | Endotheline and NO/Arahidonic acid metabolites | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 3 | Serotonin and Renin-Angiotensin-Kinin | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 4 | Introduction to autonomic nervous system and parasympathomimetic drugs | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 5 | Parasympatholytic drugs | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 6 | Sympathomimetic drugs and ganglion blockers | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 7 | Antihypertensive drugs and diuretics I | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 8 | Antihypertensive drugs and diuretics II | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 9 | Congestive heart failure and antianginal drugs | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 10 | Hypolipidemic agents | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 11 | Anticoagulants and arrhythmics | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 12 | Antitussives, mucolytics and expectorants | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 13 | Bronchodilators | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| 14 | Drugs used in electrolite and acid-base imbalance disorders | The student should study the topics communicated to students and recommended resources prior to the lesson. |
| Resources |
| 1.Kayaalp, SO: Rasyonel Tedavi Yönünden Tıbbi Farmakoloji, Ankara. 2.Hardman JG, Limbird LE, Eds.: Goodman and Gilman’s The Pharmacological Basis of Therapeutics, New York. 3.Katzung & Trevor: Farmakoloji, Ankara. |
| 1, 2, 3, Lecturer notes |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | PQ-1. Skilfully use information technology to access, follow, evaluate and apply current knowledge in the field of Pharmaceutical Sciences. | X | |||||
| 2 | PQ-2. Have advanced knowledge in APIs and DPs. | X | |||||
| 3 | PQ-3. Collaborate with the experts for collection, interpretation, application and declaration of data in Pharmaceutical Sciences field. | X | |||||
| 4 | PQ-4. Provide best patient counseling services and medication therapy management using his/her knowledge and pharmaceutical information systems to improve the quality of life and safety of patient. | X | |||||
| 5 | PQ-5. Capable of organizing and administering a drugstore as per responsibilities prescribed under the Pharmacy Law, using skills, knowledge and advanced technology systems. | X | |||||
| 6 | PQ-6. Skilfully use computer programs and advanced technology related to the Pharmaceutical Sciences. | X | |||||
| 7 | PQ-7. Provide solutions to the professional issues using scientific knowledge and data. | X | |||||
| 8 | PQ-8. Perform identification, quality control and standardization of the drug products. | X | |||||
| 9 | PQ-9. Prepare and implement developmental plans for his/her subordinates, frequently evaluate their progress and make necessary adjustments. | X | |||||
| 10 | PQ-10. Capable of conducting independent studies with his/her advanced knowledge in pharmaceutical sciences, takes responsibilities in professional organizations and efficiently collaborates with the members of his/her own organization as well as other organizations. | X | |||||
| 11 | PQ-11. Clearly show signs of adoption of life-long learning and openness to further development. | X | |||||
| 12 | PQ-12. Critically evaluate their knowledge in pharmaceutical sciences. | X | |||||
| 13 | PQ-13. Closely follow and evaluate the national and international professional developments. | X | |||||
| 14 | PQ-14. Record and document all professional activities and applications. | X | |||||
| 15 | PQ-15. Communicate all necessary information about medicines to patient, medical personnel and public. | X | |||||
| 16 | PQ-16. Proficient in English to communicate and follow current knowledge in pharmaceutical sciences. | X | |||||
| 17 | PQ-17. Inform officials and organizations about the issues with the quality assurance of pharmaceutical products. | X | |||||
| 18 | PQ-18. Actively involve in the preparation of APIs, every stage of the formulation and production of DPs. | X | |||||
| 19 | PQ-19. Knowledgable in the regulatory rules of new drug application, data protection and patent issues and understand their interrelationship. | X | |||||
| 20 | PQ-20. Have awareness of his/her duties, rights and responsibilities and act based on Pharmacy Law and high professional ethical standards. | X | |||||
| 21 | PQ-21. Familiar with and actively pursue the personal and public health, environmental, and work safety issues. | X | |||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 40 | |
| Rate of Final Exam to Success | 60 | |
| Total | 100 | |